Close Menu

Applied Markets

News on genetics and genomics applications in the Ag-Bio, Veterinary, Forensics, Food Safety, and Environmental Testing markets.

The company is enrolling up to 400 patients in its LIBRETTO-431 trial to evaluate survival and response to selpercatinib.